Sort
261,768 grants matching “gene therapy”
Treg-depleting immunotherapy
$1,188,595Peter David Suzdak · Sonoval Llc · R44 · FY2021 · CA
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$1,188,387Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Basic and Translational Research iPSC-based hematologic and vascular therapies
$1,188,317John P Cooke · Stanford University · U01 · FY2011 · HL
MOLECULAR AND CELLULAR BIOLOGY OF HIV ENCEPHALOPATHY
$1,188,269University Of Pennsylvania · P01 · FY2001 · NS
Rho GTPase inhibitor for refrigerated platelet storage
$1,188,244Brittany De Kouchkovsky · Ogb4 Inc · R44 · FY2024 · HL
Innate inflammatory responses during pulmonary infections
$1,188,232Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,188,028Yale University · P01 · FY2000 · CA
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
$1,188,023Yuri Sergeev · National Eye Institute · ZIA · FY2025 · EY
CER on CAM Antioxidant Therapies (CERCAT)
$1,188,000Balz B Frei · Oregon State University · P01 · FY2012 · AT
Center for Herbal Research on Colorectal Cancer
$1,188,000Chun-Su Yuan · University Of Chicago · P01 · FY2010 · AT
CER on CAM Antioxidant Therapies (CERCAT)
$1,188,000Balz B Frei · Oregon State University · P01 · FY2011 · AT
Parasitic Ulcer Treatment Trial
$1,187,979Jeremy David Keenan · University Of California, San Francisco · UG1 · FY2025 · EY
Niche-induced signaling in HSCP transplantation
$1,187,913Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2011 · HL
More Complete Assessment of DNA Variation in Age-Related Macular Degeneration
$1,187,839Goncalo Rocha Abecasis · University Of Michigan At Ann Arbor · R01 · FY2012 · EY
Molecular genetics of MLL-associated leukemia
$1,187,822Loyola University Chicago · P01 · FY2005 · CA
Physicochemical Cues and Their Roles in the Angiogenic Switch
$1,187,808Claudia Fischbach · Cornell University · U54 · FY2012 · CA
Preclinical characterization of a novel neuropeptide for inducing "on-demand" voiding
$1,187,722Edward Burgard · Dignify Therapeutics, Llc · U44 · FY2021 · NS
Cancer cell adaptation to metabolic stress
$1,187,477M. Celeste Simon · University Of Pennsylvania · P01 · FY2012 · CA
Mutational and Functional Analysis of Sporadic Malignant Melanoma
$1,187,324Yardena Samuels · National Human Genome Research Institute · ZIA · FY2012 · HG
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,187,307Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Prenatal Treatment of Down Syndrome to Improve Brain Development and Neurocognition
$1,187,025Diana Bianchi · National Human Genome Research Institute · ZIA · FY2022 · HG
Development of Transplant Strategies Uniquely Responsive to the Needs of Children
$1,186,911Allan D. Kirk · Emory University · U01 · FY2008 · AI
Molecular therapy for CF and genetic diseases
$1,186,890James M Wilson · University Of Pennsylvania · P30 · FY2009 · DK
Investigations of Methylmalonic Acidemia and Related Disorders
$1,186,657Charles P Venditti · National Human Genome Research Institute · ZIA · FY2016 · HG
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$1,186,626Michael D Geschwind · University Of California, San Francisco · R01 · FY2021 · AG